Form 4: Alignment Healthcare Executive Sells 14,500 Shares Under 10b5-1 Plan
SEC Form 4 Filing
Hakan Kardes, Chief Experience Officer at Alignment Healthcare, sold 14,500 shares of common stock at a weighted average price of $14.9846 per share under a pre-arranged 10b5-1 trading plan.
Summary
- Hakan Kardes, the Chief Experience Officer of Alignment Healthcare, sold 14,500 shares of the company's common stock on January 24, 2025.
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2024.
- The shares were sold at a weighted-average price of $14.9846, with individual transactions ranging from $14.98 to $15.00 per share.
- Following the transaction, Mr. Kardes still beneficially owns 295,444 shares of Alignment Healthcare stock.
Sentiment
Score: 5
Explanation: The document describes a routine stock sale by an executive under a pre-arranged plan. It is a neutral event with no significant positive or negative implications.
Risks
- Executive stock sales can sometimes be perceived negatively by the market, potentially impacting investor sentiment.
Industry Context
Executive stock sales are a common occurrence in publicly traded companies and are often part of pre-arranged trading plans to avoid accusations of insider trading. This transaction is not unusual and is likely part of the executive's personal financial planning.
Comparison to Industry Standards
- Rule 10b5-1 trading plans are a standard practice for corporate executives to sell shares without being accused of insider trading.
- The volume of shares sold is relatively small compared to the total outstanding shares of the company, suggesting it is not a major event.
- Other executives in similar healthcare companies often use 10b5-1 plans for stock sales.
Stakeholder Impact
- The stock sale may have a minor impact on shareholder sentiment, but it is unlikely to significantly affect the company's operations or financial performance.
Key Dates
| Date | Description |
|---|---|
| 03/14/2024 | Date of adoption of the Rule 10b5-1 trading plan. |
| 01/24/2025 | Date of the stock sale transaction. |
Keywords
insider trading, stock sale, 10b5-1 plan, executive, Alignment Healthcare, ALHC, Hakan Kardes
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.